1. Effect of exogenously administered glucagon versus spontaneous endogenous counter‐regulation on glycaemic recovery from insulin‐induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin. Issue 11 (3rd July 2014) Authors: Krentz, A. J.; Morrow, L.; Petersson, M.; Norjavaara, E.; Hompesch, M. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 11(2014:Nov.) Page Start: 1096 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacodynamic effects of the oral glucokinase activator AZD6370 after single doses in healthy volunteers assessed with euglycaemic clamp. Issue 1 (9th September 2012) Authors: Sjöstrand, M.; Ericsson, H.; Hartford, M.; Norjavaara, E.; Eriksson, J. W. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 1(2013:Jan.) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗